Nyxoah S.A.
Market Cap
$116.51M
P/E Ratio
-1.21
EPS
$-2.57
Dividend Yield
0.00%
52-Week Range
$3.05 — $11.87
Volume
42.80K
Avg Volume
48.95K
Beta
0.62
P/E (TTM)
-1.21
Forward P/E
—
PEG Ratio
0.22
P/S (TTM)
19.83
P/B (TTM)
2.20
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.01%
ROA (TTM)
-0.89%
ROIC
—
Gross Margin
0.64%
Operating Margin
-14.75%
Net Margin
—
Debt/Equity
0.42
Current Ratio
1.70
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.16%
EPS Growth (5Y)
-0.44%
Sales Growth (3Y)
+1.02%
Sales Growth (5Y)
+2.88%
EPS Est (This Year)
$-2.11
EPS Est (Next Year)
$-1.48
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.60
Price Target Range
Consensus Target: $10.00(220.5% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
37.34M
Float
20.74M
Free Float %
55.55%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
BE
Exchange
NASDAQ
IPO Date
2021-04-28
Employees
183
CEO
Olivier Taelman
Index Membership
—
Website
https://www.nyxoah.com
Nyxoah S.A. (NYXH) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $116.51M, a P/E ratio of -1.21, NYXH is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NYXH against other stocks using dozens of fundamental and technical filters.
Nyxoah S.A. (NYXH) has a trailing twelve-month (TTM) P/E ratio of -1.21. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Nyxoah S.A. (NYXH) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Nyxoah S.A. (NYXH) has a market capitalization of $116.51 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.